Is radical scavenging necessary in the treatment of inflammatory bowel disease?

PubWeight™: 1.39‹?› | Rank: Top 5%

🔗 View Article (PMID 1985062)

Published in Gastroenterology on February 01, 1991

Authors

H Allgayer, R Gugler, P Böhme, M Schmidt, P Höfer, W Kruis

Articles citing this

Free radical scavengers and inflammatory bowel disease. Gastroenterology (1991) 0.75

Articles by these authors

(truncated to the top 100)

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1. Science (2003) 19.77

MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene (2007) 10.79

Contribution of anthropogenic and natural sources to atmospheric methane variability. Nature (2006) 5.66

Coronary magnetic resonance angiography for the detection of coronary stenoses. N Engl J Med (2001) 4.73

Electrographic seizures and periodic discharges after intracerebral hemorrhage. Neurology (2007) 4.22

Mechanism of met oncogene activation. Cell (1986) 4.20

GroE facilitates refolding of citrate synthase by suppressing aggregation. Biochemistry (1991) 2.92

How practical are recommendations for dietary control in phenylketonuria? Lancet (2002) 2.82

Protein conformational relaxation and ligand migration in myoglobin: a nanosecond to millisecond molecular movie from time-resolved Laue X-ray diffraction. Biochemistry (2001) 2.73

A diagnostic score for the irritable bowel syndrome. Its value in the exclusion of organic disease. Gastroenterology (1984) 2.70

Infliximab induces apoptosis in monocytes from patients with chronic active Crohn's disease by using a caspase-dependent pathway. Gastroenterology (2001) 2.69

A habitable fluvio-lacustrine environment at Yellowknife Bay, Gale crater, Mars. Science (2013) 2.50

Drug interactions with cimetidine. Clin Pharmacokinet (1982) 2.49

Enzymes for RNA sequence analysis. Preparation and specificity of exoplasmodial ribonucleases I and II from Physarum polycephalum. J Biol Chem (1978) 2.44

Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters. Br J Cancer (2002) 2.38

The process of metastasisation for breast cancer. Eur J Cancer (2003) 2.30

The base of the proteasome regulatory particle exhibits chaperone-like activity. Nat Cell Biol (1999) 2.22

European evidence-based Consensus on the management of ulcerative colitis: Current management. J Crohns Colitis (2008) 2.14

Early infant mortality in West Germany before and after Chernobyl. Lancet (1989) 2.07

The yeast cell wall and septum as paradigms of cell growth and morphogenesis. J Biol Chem (2001) 2.05

Facilitating networks of information. Proc AMIA Symp (2000) 2.05

A PC program for estimating organ dose and effective dose values in computed tomography. Eur Radiol (1999) 2.03

Mesalazine inhibits activation of transcription factor NF-kappaB in inflamed mucosa of patients with ulcerative colitis. Am J Gastroenterol (2000) 2.03

Extension of platelet shelf life from 4 to 5 days by implementation of a new screening strategy in Germany. Vox Sang (2011) 2.02

New gentamicin-resistance and lacZ promoter-probe cassettes suitable for insertion mutagenesis and generation of transcriptional fusions. Gene (1995) 1.94

The mycosubtilin synthetase of Bacillus subtilis ATCC6633: a multifunctional hybrid between a peptide synthetase, an amino transferase, and a fatty acid synthase. Proc Natl Acad Sci U S A (1999) 1.87

Impaired cimetidine absorption due to antacids and metoclopramide. Eur J Clin Pharmacol (1981) 1.86

Coherent membrane supports for parallel microsynthesis and screening of bioactive peptides. Biopolymers (2000) 1.82

Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer. Oncogene (2011) 1.75

Genetic analysis of inflammatory bowel disease in a large European cohort supports linkage to chromosomes 12 and 16. Gastroenterology (1998) 1.73

International survey on NAT testing of blood donations: expanding implementation and yield from 1999 to 2009. Vox Sang (2011) 1.69

Interaction of mite allergens Der p3 and Der p9 with protease-activated receptor-2 expressed by lung epithelial cells. J Immunol (2001) 1.68

Sensitivity and specificity of a screening test to document traumatic experiences and to diagnose post-traumatic stress disorder in ARDS patients after intensive care treatment. Intensive Care Med (1999) 1.67

Tumor suppressor Pdcd4 inhibits invasion/intravasation and regulates urokinase receptor (u-PAR) gene expression via Sp-transcription factors. Oncogene (2007) 1.62

Head to head comparison of dobutamine-transoesophageal echocardiography and dobutamine-magnetic resonance imaging for the prediction of left ventricular functional recovery in patients with chronic coronary artery disease. Eur Heart J (2000) 1.62

Physical mapping of new DNA probes near the fragile X mutation (FRAXA) by using a panel of cell lines. Am J Hum Genet (1990) 1.60

The use of malaria antibody tests in the prevention of transfusion-transmitted malaria. Vox Sang (2010) 1.60

Efficient generation of a hepatitis B virus cytotoxic T lymphocyte epitope requires the structural features of immunoproteasomes. J Exp Med (2000) 1.59

The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patients. Br J Cancer (2013) 1.57

MicroRNA-520/373 family functions as a tumor suppressor in estrogen receptor negative breast cancer by targeting NF-κB and TGF-β signaling pathways. Oncogene (2011) 1.57

Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance. Cancer (1996) 1.56

Family of middle repetitive DNA sequences in the mouse genome with structural features of solitary retroviral long terminal repeats. Proc Natl Acad Sci U S A (1983) 1.54

[177Lu-DOTA(0),Tyr3] octreotate for somatostatin receptor-targeted radionuclide therapy. Int J Cancer (2001) 1.53

Incomplete X chromosome dosage compensation in chorionic villi of human placenta. Proc Natl Acad Sci U S A (1985) 1.53

Analysis of mammalian 20S proteasome biogenesis: the maturation of beta-subunits is an ordered two-step mechanism involving autocatalysis. EMBO J (1996) 1.53

Activated protein C inhibits lipopolysaccharide-induced nuclear translocation of nuclear factor kappaB (NF-kappaB) and tumour necrosis factor alpha (TNF-alpha) production in the THP-1 monocytic cell line. Br J Haematol (2000) 1.51

[18F]-fluorodeoxyglucose-positron emission tomography for the assessment of histopathologic response and prognosis after completion of neoadjuvant chemotherapy in gastric cancer. J Surg Oncol (2010) 1.49

Allergens in Hymenoptera venoms. XXIII. Venom content of imported fire ant whole body extracts. Ann Allergy (1991) 1.48

Remission of refractory Crohn's disease by high-dose cyclophosphamide and autologous peripheral blood stem cell transplantation. Aliment Pharmacol Ther (2012) 1.47

Characterization of a cis-acting sequence in the Pol region required to transfer human foamy virus vectors. J Virol (1998) 1.46

Pharmacokinetics of pindolol in man. Eur J Clin Pharmacol (1974) 1.46

[Irritable bowel syndrome: German consensus guidelines on definition, pathophysiology and management]. Z Gastroenterol (2011) 1.46

Risk and outcome analysis of renal replacement therapies in patients after cardiac surgery with pre-operatively normal renal function. Anaesthesia (2009) 1.45

Low serum 25-hydroxyvitamin D concentrations are associated with insulin resistance and obesity in women with polycystic ovary syndrome. Exp Clin Endocrinol Diabetes (2006) 1.45

Vaccination against hepatitis B: comparison of three different vaccination schedules. J Infect Dis (1989) 1.45

Novel radiotracers for imaging the serotonin transporter by positron emission tomography: synthesis, radiosynthesis, and in vitro and ex vivo evaluation of (11)C-labeled 2-(phenylthio)araalkylamines. J Med Chem (2000) 1.44

The prothrombin gene variant G20210A but not factor V leiden may be associated with veno-occlusive disease following BMT. Bone Marrow Transplant (1999) 1.43

[Typical angina pectoris complaints without coronary macroangiopathy]. Dtsch Med Wochenschr (2005) 1.43

Hepatitis B vaccination: how long does protection last? Lancet (1984) 1.43

Microbial diversity of the brine-seawater interface of the Kebrit Deep, Red Sea, studied via 16S rRNA gene sequences and cultivation methods. Appl Environ Microbiol (2001) 1.43

Femtosecond spontaneous-emission studies of reaction centers from photosynthetic bacteria. Proc Natl Acad Sci U S A (1992) 1.42

Molecular analysis of the Rhizobium meliloti mucR gene regulating the biosynthesis of the exopolysaccharides succinoglycan and galactoglucan. Mol Plant Microbe Interact (1995) 1.42

MIBI scintigraphy in hypofunctioning thyroid nodules--can it predict the dignity of the lesion? Nuklearmedizin (2009) 1.42

Microfluidic structures for flow cytometric analysis of hydrodynamically focussed blood cells fabricated by ultraprecision micromachining. Lab Chip (2009) 1.42

Clinical pharmacokinetics of valproic acid. Clin Pharmacokinet (1980) 1.42

Sphingosine kinase-mediated Ca2+ signalling by G-protein-coupled receptors. EMBO J (1998) 1.41

Endothelial dysfunction and type 2 diabetes. Part 2: altered endothelial function and the effects of treatments in type 2 diabetes mellitus. Diabetes Metab (2001) 1.41

Curiosity at Gale crater, Mars: characterization and analysis of the Rocknest sand shadow. Science (2013) 1.40

Polo-like kinase isoform expression is a prognostic factor in ovarian carcinoma. Br J Cancer (2004) 1.39

Intrinsic and extrinsic corrugation of monolayer graphene deposited on SiO2. Phys Rev Lett (2009) 1.39

Mesalazine granules are superior to Eudragit-L-coated mesalazine tablets for induction of remission in distal ulcerative colitis - a pooled analysis. Aliment Pharmacol Ther (2011) 1.39

[The duodenojejunal flexure--a gap in the routine diagnosis of gastrointestinal bleeding]. Dtsch Med Wochenschr (1999) 1.38

Acquired protein C dysfunction but not decreased activity of thrombomodulin is a possible marker of thrombophilia in patients with lupus anticoagulant. J Lab Clin Med (1995) 1.38

Monitoring theophylline levels in serum and saliva using fluorescence polarization immunoassay and Seralyzer. Pediatr Pulmonol (1989) 1.37

The relationship between fibromyalgia and interstitial cystitis. J Psychiatr Res (1997) 1.37

EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer. Ann Oncol (2012) 1.37

Diagnosis and metaphylaxis of stone disease. Consensus concept of the National Working Committee on Stone Disease for the upcoming German Urolithiasis Guideline. World J Urol (2005) 1.36

High in vitro development after somatic cell nuclear transfer and trichostatin A treatment of reconstructed porcine embryos. Theriogenology (2008) 1.36

Extraction of accurate structure-factor amplitudes from Laue data: wavelength normalization with wiggler and undulator X-ray sources. J Synchrotron Radiat (2000) 1.36

Urinary miR-210 as a mediator of acute T-cell mediated rejection in renal allograft recipients. Am J Transplant (2011) 1.36

Reconstitution of a heat shock effect in vitro: influence of GroE on the thermal aggregation of alpha-glucosidase from yeast. Biochemistry (1991) 1.34

PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel and CMF versus a standard-dosed epirubicin/cyclophosphamide followed by paclitaxel ± darbepoetin alfa in primary breast cancer--results at the time of surgery. Ann Oncol (2011) 1.33

Clinical evaluation of a recombinant hepatitis B vaccine. Lancet (1984) 1.33

Structure and genomic organization of a new family of murine retrovirus-related DNA sequences (MuRRS). Nucleic Acids Res (1985) 1.33

The effect of pindolol on exercise-induced cardiac acceleration in relation to plasma levels in man. Clin Pharmacol Ther (1975) 1.33

Chronic inflammatory bowel disease and cancer. Hepatogastroenterology (2000) 1.32

Clinical pharmacokinetics of cimetidine. Clin Pharmacokinet (1984) 1.32

Cimetidine for anastomotic ulcers after partial gastrectomy. A randomized controlled trial. N Engl J Med (1979) 1.32

Transient transgene expression of decorin in the lung reduces the fibrotic response to bleomycin. Am J Respir Crit Care Med (2001) 1.32

Induction of apoptosis and activation of the caspase cascade by anti-EGF receptor monoclonal antibodies in DiFi human colon cancer cells do not involve the c-jun N-terminal kinase activity. Br J Cancer (2000) 1.31

Individual development and uPA-receptor expression of disseminated tumour cells in bone marrow: a reference to early systemic disease in solid cancer. Nat Med (1995) 1.30

Effects of a chemotactic factor, N-formylmethionyl peptide, on adherence, superoxide anion generation, phagocytosis, and microtubule assembly of human polymorphonuclear leukocytes. J Lab Clin Med (1979) 1.30

Regulation of muscarinic acetylcholine receptor sequestration and function by beta-arrestin. J Biol Chem (1999) 1.29

Omeprazole inhibits oxidative drug metabolism. Studies with diazepam and phenytoin in vivo and 7-ethoxycoumarin in vitro. Gastroenterology (1985) 1.29

The HSM sentence test as a tool for evaluating the speech understanding in noise of cochlear implant users. Am J Otol (1997) 1.29

Cimetidine plasma concentration-response relationships. Clin Pharmacol Ther (1981) 1.29

Immune response to hepatitis B revaccination. J Med Virol (1988) 1.28

PREPARE trial: a randomized phase III trial comparing preoperative, dose-dense, dose-intensified chemotherapy with epirubicin, paclitaxel, and CMF versus a standard-dosed epirubicin-cyclophosphamide followed by paclitaxel with or without darbepoetin alfa in primary breast cancer--outcome on prognosis. Ann Oncol (2011) 1.26

Inhibition of polymorphonuclear leukocyte adherence by prostacyclin. J Lab Clin Med (1980) 1.24

Gene expression profiling of liver metastases and tumour invasion in pancreatic cancer using an orthotopic SCID mouse model. Br J Cancer (2007) 1.23